Hospital Pharmacy presents this new feature to keep pharmacists abreast of new publications in the medical/pharmacy literature. Articles of interest will be abstracted monthly regarding a broad scope of topics.
Get full access to this article
View all access options for this article.
References
1.
Ioannides-DemosL.L., ProiettoJ., TonkinA.M., McNeilJ.J.Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf.2006; 29: 277–302.
2.
DeRykeC.A., KutiJ.L., MansfieldD., DanaA., NicolauD.P.Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection. Am J Health Syst Pharm.2006; 63: 750–755.
3.
WuY., MakuchR.W.Detecting rare adverse events in postmarketing studies: Sample size considerations. Drug Inf J.2006; 40: 89–98.
4.
SchrimsherR.H., FreemanM.K., KendrachM.A survey of drug information resources in Alabama pharmacy facilities. Drug Inf J.2006; 40: 51–60.
5.
TrygstadT.K., HansenR.A., WegnerS.E.Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. J Manag Care Pharm.2006; 12: 108–120.
6.
NguyenL.N., GuthrieS.K.Risperidone treatment of bipolar mania. Ann Pharmacother.2006; 40: 674–682.
7.
BrixnerD.I., SaidQ., Corey-LisleP.K., TuomariA.V., L'italienG.J., StockdaleW., OderdaG.M.Natrualistic impact of second generation antipsychotics on weight gain. Ann Pharmacother.2006; 40: 626–632.
8.
GurwitzJ.H.Serious adverse drug effects-seeing the trees through the forest. N Engl J Med.2006; 354: 1413–1415.
9.
WinbladB., KilanderL., EriksonS.. Donepezil in patients with severe Alzheimer's disease: double blind, parallel group, placebo controlled study. Lancet.2006; 367: 1057–1065.
10.
ZalogaG.P.Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: assessment of outcomes. Lancet.2006; 367: 1101–1111.
11.
RaffaR.B., DuongP.V., FinneyJ.. Is chemo-fog/chemo-brain caused by cancer chemotherapy?J Clin Pharm Ther.2006; 31: 129–138.
12.
LexchinJ.Is there still a role for spontaneous reporting of adverse drug reactions?CMAJ.2006; 174: 191–192.
13.
BaglinT., BarrowcliffeT.W., CohenA., GreavesM., The British Committee for Standards in Hematology. Guidelines on the use and monitoring of heparin. Br J Hematol.2006; 133: 19–34.
14.
UhlK., CoxE., RoganR.. Thalidomide use in the US: experience with pregnancy testing in the S.T.E.P.S. programme. Drug Saf.2006; 29: 321–329.
15.
GentileS.Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis. Drug Saf.2006; 29: 303–319.
16.
HerdeiroM.T., FigueirasA., PoloniaJ., Gestal-OteroJ.J.Influence of pharmacists' attitudes on adverse drug reaction reporting: a case control study in Portugal. Drug Saf.2006; 29: 331–340.
17.
ReidC.N., MartinR.M., SterneJ.A.C., DaviesA.N., HanksG.W.Oxycodone for cancer related pain: meta-analysis of randomized controlled trials. Arch Intern Med.2006; 166: 837–843.
18.
PodichettyV.K., BooherJ., WhitfieldM., BiscupR.S.Assessment of internet use and effects among healthcare professionals: a cross sectional survey. Postgrad Med J.2006; 82: 274–279.
19.
WelchS.J.Preparing manuscripts for online submission: basic information and avoidance of common pitfalls. Chest.2006; 129: 822–825.
20.
VallurupalliN.G., GoldhaberS.Z.Gastrointestinal complications of dual antiplatelet therapy. Circulation.2006; 113: e655–e658.
21.
BentS., PaulaA., AvinsA.L.Brief communications: Better ways to question patients about adverse medical events. A randomized controlled trial. Ann Intern Med.2006; 144: 257–251.
22.
IoannidisJ.P., MulrowC.D., GoodmanS.N.Adverse events: the more you search, the more you find. Ann Intern Med.2006; 144: 298–300.
